Spring direct naar de hoofdnavigatie of de inhoud
‘To explore, together with a client, how the best IP protection can be obtained is for me the logical next step after an invention has been made.’
Frits Michiels

Frits Michiels

  • Life Sciences
  • European and Dutch Patent Attorney
  • Valuation specialist
  • Partner

Frits Michiels has had an extensive scientific career in both knowledge institutes and biotech companies. From 2004, he was employed as IP manager at Galapagos Genomics BV and subsequently also at other Dutch biotech startups, such as Agendia and Merus. He has worked for V.O. since 2006.

Continue reading

He is specialized in biochemistry, molecular biology, cell biology, diagnostics, signal transduction, and medical biotechnology. His clients are primarily knowledge institutes and start ups. He is involved in patent prosecution and strategic advice.

Working experience

  • Patent Attorney, V.O. (2006-present)
  • Merus (2006)
  • Galapagos Genomics (1999-2005)
  • Senior Scientist at the Netherlands Cancer Institute (1994-1998)
  • Post-Doc, Amsterdam Medical Center (1991-1993)
  • PhD research at Max Planck Institute for Biochemistry, Munich (1985-1990)

Education

  • PhD in Genetics, Radboud University Nijmegen (1990)
  • MSc in Microbiology, Radboud University Nijmegen (1984)

Publications

  • Michiels, GAM Damages extended to after termination of a tort. MIP Vol 205: 94-95 (2011)
  • JP ten Klooster, EE Evers, L Janssen, LM Machesky, F Michiels, P Hordijk and JG Collard. Biochem J. 397, 39–45 (2006)
  • GJ Arts, E Langemeijer, R Tissingh, L Ma, H Pavliska, K Dokic, R Dooijes, E Mesić, R Clasen, F Michiels, J van der Schueren, M Lambrecht, S Herman, R Brys, K Thys, M Hoffmann, P Tomme, H van Es. Genome Res 13, 2325-32 (2003)
  • A Malliri, RA van der Kammen, K Clark, M van der Valk, F Michiels & JG Collard. Nature 417, 867-871 (2002)
  • F Michiels et al. Nature Biotech 20, 1154-1157 (2002)
  • R Engers, E Springer, F Michiels, JG Collard, HE Gabbert. J Biol Chem 276, 41889-97 (2001)
  • WO2002057463 Swap/counter selection; a rapid cloning
  • WO2002070744 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds method
  • WO2005124342 Methods and means for treatment of osteoarthritis

Languages

  • English
  • Dutch
  • German

Also see these experts

Frits Schut

Frits Schut

  • European and Dutch Patent Attorney
  • Partner
Hajo Kraak

Hajo Kraak

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
More experts

News

Podium – Tagworks Pharmaceuticals

In this section we give a stage to start-ups and scale-ups that develop groundbreaking products or services. This time: Tagworks Pharmaceuticals from Nijmegen.Continue reading

Innovative idea? Enter the first NL Startup Competition and win €10,000 in prize money!

Groundbreaking ideas can change the world. Does your startup focus on social impact, energy transition, digital progress or solutions for the circular economy? Then enter the first ever NL Startup Competition and win € 10,000 prize money, valuable networking opportunities and new knowledge and inspiration. V.O. Patents & Trademarks is pleased to support this competition […]Continue reading

RVO helps entrepreneurs do business

Entrepreneurs make the Netherlands economically stronger and society increasingly sustainable. The Netherlands Enterprise Agency (RVO) contributes to this by encouraging them to invest in solutions to societal challenges.Continue reading

Events

JCI Flemish-Brabant Young Entrepreneur of the Year 2024

De Hoorn, Sluisstraat, Leuven, Belgium

JCI Flemish-Brabant Young Entrepreneur of the Year. Our society is constantly changing. And let that be precisely the goal of Junior Chamber International ("JCI"): to bring about positive changes in our society.

Continue reading

Knowledge for Growth 2024

Flanders Meeting & Convention Center Antwerp, Koningin Astridplein, Antwerp, Belgium

The crème de la crème of the Belgian life sciences community is present at flanders.bio's annual Knowledge for Growth conference, which brings together decision-makers from the biotech, pharma and medtech, agriculture and chemical industries, as well as investors, universities, top research institutions, policy makers and competence providers.

Continue reading

INTA Annual Meeting 2024

Georgia World Congress Center, Andrew Young International Boulevard Northwest, Atlanta, Georgia, USA

Meet the most influential trademark professionals from around the world and from all industries at the largest gathering of its kind at INTA's annual meeting.

Continue reading